SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.57-0.8%Nov 3 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (1327)5/16/2002 6:24:49 PM
From: scaram(o)uche  Read Replies (1) of 1475
 
Thursday May 16, 6:00 pm Eastern Time
Press Release
SOURCE: The Center for Bioethics and Human Dignity
The Center for Bioethics and Human Dignity Denounces Patenting of Human Cloning: Calls for Legislation to Ban Practice
CHICAGO, May 16 /PRNewswire/ -- Today it was discovered by Patent Watch Project that the U.S. Patent Office (PTO) has awarded a patent on human reproductive cloning to the University of Missouri. The university shares its financial interest in the patent with Biotransplant, Inc., a Massachusetts- based biotech company.

The patent, US 6,211,429, is written so that it extends to both humans and animals as well as any other "products" created by the process of cloning. "Products" theoretically could include any human clones -- embryos, fetuses, and children. The patent encompasses human beings because it covers a "method for producing a cloned mammal" and specifically includes methods using "human oocytes." Patent Watch Project's analysis concludes that the inclusion of human cloning in the patent may have been intentional since the patent office recognized that it covered "all mammals" and included "human oocytes."

CBHD President Comments...

John F. Kilner, President of The Center for Bioethics and Human Dignity, said concerning the discovery, "The possible patenting of human beings, no matter their age, size or stage of existence, would be a crushing blow to essential human rights and dignity.

"What is slavery other than one person owning another? By giving a company ownership of human beings produced through a cloning process, this patent apparently gives government approval to a new form of slavery. If such is the case, people should have the same kind of outrage over this as if an African- American child were sold today on the auction block to the first bidder. There must be a legislative ban on this kind of practice. Human beings are not property."

For More Information...

For the Executive Summary of Patent Watch Project's discovery and analysis, please visit cloninginformation.org

About The Center for Bioethics and Human Dignity

The Center for Bioethics and Human Dignity is a 501(c) 3 non-profit think tank located in Chicago, Illinois. It's mission is to develop reasoned perspectives on all of today's bioethical issues and to disseminate them to health care professionals, academia, cultural and church leaders, public policy makers and the media in order to protect human dignity.

Organization Website: cbhd.org

SOURCE: The Center for Bioethics and Human Dignity

(no brains..... the assignee has no intent to clone humans. why not remove the claim language, so that ANYBODY can do the work without violating a patent and/or patent treaty? numbskulls.)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext